Specialty Pharmacy/Biosimilars
Specialty Pharmaceuticals and Related FDA Approved Products Policy 0112 03/01/200 Introduced 02/01/2006 Revised 12/01/2010 Revised 02/21/2021 Revised | AMCP supports the leadership role of pharmacists within specialty pharmacy, including ensuring the proper use, storage, control, safe handling, preparation, distribution, administration, and care management processes for these medications. Specialty pharmaceuticals are generally high-cost medications, usually prescribed for people with complex or chronic medical conditions, or they may be medications that typically exhibit one or both of the following characteristics: • drugs that have unique monitoring, storage, or shipment requirements; and • drugs that require additional patient education and support from a health care team which includes a pharmacist with specialty medication experience.
|
Restricted Distribution of Pharmaceuticals Policy 0119 11/01/2001 Introduced 02/01/2006 Revised 12/01/2010 Revised 04/07/2015 Revised | AMCP generally opposes any restrictions on the distribution of pharmaceutical products either by the pharmaceutical industry or as a condition for FDA-approval. AMCP acknowledges that circumstances may occur with the use of specific medications that require special distribution, monitoring and management processes. As long as, 4. There is scientific consensus that the requirements are necessary and represent the least restrictive means to achieve safe and effective patient care; 6. All requirements are stated in functional, objective terms so that any provider who meets the criteria may participate in the care of patients; 7. The requirements do not interfere with the professional practice of pharmacists, physicians, or other appropriately qualified healthcare professionals. |
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.